search
Back to results

Efficacy of Game-Based EMG-Biofeedback Therapy in Post-Stroke Dysphagia

Primary Purpose

Stroke, Dysphagia, Surface Electromyography

Status
Completed
Phase
Not Applicable
Locations
Turkey
Study Type
Interventional
Intervention
With EMG-Biofeedback
Without EMG-Biofeedback
Usual Care
Sponsored by
Kirsehir Ahi Evran University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Stroke

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: History of hemorrhagic or ischemic stroke longer than 3 months Being over the age of eighteen Level ≤ 6 on the Functional Oral Intake Scale (FOIS) Post-stroke onset of swallowing complaints Ability to communicate with the patient and carry out the given commands Mini mental test evaluation ≥ 24 points Absence of concomitant serious systemic disease (unregulated hypertension, decompensated heart failure, malignancy, infection, pacemaker, epilepsy, etc.) Detection of pathology in the oropharyngeal phase of swallowing in videofluoroscopic evaluation Not taking any swallowing-related treatment in the last 3 months Exclusion Criteria: History of neoplastic disease and/or radiotherapy to the head and neck region Having additional musculoskeletal disease or non-stroke neurologic disease that may cause swallowing disorders Unable to communicate or carry out commands Inability to maintain head-holding balance Patients with severe pathology in bolus formation or delivery of the bolus to the pharynx during the oral swallowing phase

Sites / Locations

  • Kocaeli University

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

EMG-Biofeedback

Classic Therapy

Arm Description

Mendelsohn maneuver and effortful swallow exercise will be applied through game-based emg-biofeedback to patients with post-stroke dysphagia.

Mendelsohn maneuver and effortful swallow exercise with only verbal feedback will be applied to patients with post-stroke dysphagia.

Outcomes

Primary Outcome Measures

Gugging Swallowing Screen (GUSS)
It is used to determine the severity of dysphagia and the risk of aspiration in patients with acute stroke. It is evaluated out of 20 points. It recommends videofluoroscopy as an advanced examination for patients with a score of less than 20.
Functional Oral Intake Scale (FOIS)
7 point scale from 1-7. Higher number indicated increased amount and normality of oral intake.
Penetration Aspiration Scale (PAS)
Videofluoroscopic evaluation is performed. It is an 8-point scale. The higher the number, the greater the increase in penetration/aspiration. 1 means no penetration and no aspiration. 8 means there is aspiration and there is no patient response.
Functional Dysphagia Scale (FDS)
Videofluoroscopic evaluation is performed. It is a total of 100 points scale. A higher score indicates more severe dysphagia.
Dysphagia Outcome and Severity Scale (DOSS)
Videofluoroscopic evaluation is performed. It is a 7-point scale. A score of 6 and 7 represents normal swallowing, a score of 5 represents mild dysphagia, a score of 2 to 4 represents moderate dysphagia, and a score of 1 represents severe dysphagia.
Dysphagia Handicap Index (DHI)
Dysphagia Handicap Index (DHI) is a self-assessment questionnaire which consists of 25 statements to examine three aspects of dysphagia patients' quality of life (QoL): functional, physical, and emotional. The patient can get a maximum score of 100 points.A higher score indicates a more severe swallowing disorder.

Secondary Outcome Measures

Full Information

First Posted
April 16, 2023
Last Updated
October 14, 2023
Sponsor
Kirsehir Ahi Evran University
search

1. Study Identification

Unique Protocol Identification Number
NCT05832658
Brief Title
Efficacy of Game-Based EMG-Biofeedback Therapy in Post-Stroke Dysphagia
Official Title
Efficacy of Game-Based EMG-Biofeedback Therapy in Post-Stroke Dysphagia
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Completed
Study Start Date
May 7, 2023 (Actual)
Primary Completion Date
October 14, 2023 (Actual)
Study Completion Date
October 14, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Kirsehir Ahi Evran University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study aims to determine the effectiveness of game-based biofeedback application via surface electromyography in patients with post-stroke dysphagia. The same treatment interventions will be applied with and without biofeedback, and thus the contribution of adding biofeedback to the treatment will be determined.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke, Dysphagia, Surface Electromyography, Biofeedback, Swallowing Disorder

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
33 (Actual)

8. Arms, Groups, and Interventions

Arm Title
EMG-Biofeedback
Arm Type
Experimental
Arm Description
Mendelsohn maneuver and effortful swallow exercise will be applied through game-based emg-biofeedback to patients with post-stroke dysphagia.
Arm Title
Classic Therapy
Arm Type
Active Comparator
Arm Description
Mendelsohn maneuver and effortful swallow exercise with only verbal feedback will be applied to patients with post-stroke dysphagia.
Intervention Type
Device
Intervention Name(s)
With EMG-Biofeedback
Intervention Description
Once a day for a total of 15 sessions, the Mendelsohn maneuver will be performed for 15 minutes and the effortful swallow maneuver will be performed for 15 minutes with game-based emg-biofeedback.
Intervention Type
Behavioral
Intervention Name(s)
Without EMG-Biofeedback
Intervention Description
Once a day for a total of 15 sessions, the Mendelsohn maneuver will be performed for 15 minutes and the effortful swallow maneuver will be performed for 15 minutes with only verbal feedback.
Intervention Type
Behavioral
Intervention Name(s)
Usual Care
Intervention Description
Patient and family education will be provided by the investigator. In addition, each patient will be evaluated and oral motor exercises and thermal tactile stimulation will be given to each patient when necessary.
Primary Outcome Measure Information:
Title
Gugging Swallowing Screen (GUSS)
Description
It is used to determine the severity of dysphagia and the risk of aspiration in patients with acute stroke. It is evaluated out of 20 points. It recommends videofluoroscopy as an advanced examination for patients with a score of less than 20.
Time Frame
From baseline to the end of the treatment ( 3 week)
Title
Functional Oral Intake Scale (FOIS)
Description
7 point scale from 1-7. Higher number indicated increased amount and normality of oral intake.
Time Frame
From baseline to the end of the treatment ( 3 week)
Title
Penetration Aspiration Scale (PAS)
Description
Videofluoroscopic evaluation is performed. It is an 8-point scale. The higher the number, the greater the increase in penetration/aspiration. 1 means no penetration and no aspiration. 8 means there is aspiration and there is no patient response.
Time Frame
From baseline to the end of the treatment ( 3 week)
Title
Functional Dysphagia Scale (FDS)
Description
Videofluoroscopic evaluation is performed. It is a total of 100 points scale. A higher score indicates more severe dysphagia.
Time Frame
From baseline to the end of the treatment ( 3 week)
Title
Dysphagia Outcome and Severity Scale (DOSS)
Description
Videofluoroscopic evaluation is performed. It is a 7-point scale. A score of 6 and 7 represents normal swallowing, a score of 5 represents mild dysphagia, a score of 2 to 4 represents moderate dysphagia, and a score of 1 represents severe dysphagia.
Time Frame
From baseline to the end of the treatment ( 3 week)
Title
Dysphagia Handicap Index (DHI)
Description
Dysphagia Handicap Index (DHI) is a self-assessment questionnaire which consists of 25 statements to examine three aspects of dysphagia patients' quality of life (QoL): functional, physical, and emotional. The patient can get a maximum score of 100 points.A higher score indicates a more severe swallowing disorder.
Time Frame
From baseline to the end of the treatment ( 3 week)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: History of hemorrhagic or ischemic stroke longer than 3 months Being over the age of eighteen Level ≤ 6 on the Functional Oral Intake Scale (FOIS) Post-stroke onset of swallowing complaints Ability to communicate with the patient and carry out the given commands Mini mental test evaluation ≥ 24 points Absence of concomitant serious systemic disease (unregulated hypertension, decompensated heart failure, malignancy, infection, pacemaker, epilepsy, etc.) Detection of pathology in the oropharyngeal phase of swallowing in videofluoroscopic evaluation Not taking any swallowing-related treatment in the last 3 months Exclusion Criteria: History of neoplastic disease and/or radiotherapy to the head and neck region Having additional musculoskeletal disease or non-stroke neurologic disease that may cause swallowing disorders Unable to communicate or carry out commands Inability to maintain head-holding balance Patients with severe pathology in bolus formation or delivery of the bolus to the pharynx during the oral swallowing phase
Facility Information:
Facility Name
Kocaeli University
City
Kocaeli
ZIP/Postal Code
41001
Country
Turkey

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Efficacy of Game-Based EMG-Biofeedback Therapy in Post-Stroke Dysphagia

We'll reach out to this number within 24 hrs